Printer Friendly

PRICE COMPANY CHAIRMAN ISSUES STATEMENT

 PRICE COMPANY CHAIRMAN ISSUES STATEMENT
 SAN DIEGO, Nov. 9 /PRNewswire/ -- The Price Company


(NASDAQ-NMS: PCLB) announced today that it has received inquiries related to the recent trading activity of its securities and press reports of possible acquisition interest in the company. In response, Robert Price, chairman and chief executive officer of the company, had the following statement:
 "It has been, and continues to be, the company's policy not to comment on reports of merger or acquisition activities involving the Price Company. Consequently, the company has no comment."
 -0- 11/9/92
 /CONTACT: Daniel T. Carter, vice president-finance of The Price Company, 619-581-4889/
 (PCLB) CO: The Price Company ST: California IN: SU:


TS -- NY009 -- 8476 11/09/92 08:00 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 9, 1992
Words:120
Previous Article:CAERE CORP. ANNOUNCES FAXMASTER SERVER: SHARED FAX SOFTWARE FOR WORKGROUPS
Next Article:GOODYEAR CHOOSES TRIAD DATABASES FOR AUTOMOTIVE SERVICE CENTERS
Topics:


Related Articles
CARL KARCHER ENTERPRISES ISSUES STATEMENT IN RESPONSE TO UNUSUAL TRADING VOLUME
Shareholders of Central Reserve Life Corporation Approve $40 Million Equity Funding Transaction
Panja Founder Scott Miller Returns as Chief Executive Officer; Panja Announces $5,500,000 Capital Commitment.
The Following is a Statement in Reaction to the Successful Conclusion of the Negotiations on TRIPS and Public Health From Shannon Herzfeld, PhRMA's...
Passing of Genmab A/S' Annual General Meeting - Subsequent Grant of Warrants.
Conolog Comments on the Recent Price Activity of the Company's Stock.
Aerogen, Inc. Announces Closing of Private Offering of Convertible Debentures and Warrants.
Russ Berrie and Company Announces Death of Founder, Chairman, and CEO.
Pharmasset Appoints Fredric D. Price as a Director.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters